<code id='D4976FA739'></code><style id='D4976FA739'></style>
    • <acronym id='D4976FA739'></acronym>
      <center id='D4976FA739'><center id='D4976FA739'><tfoot id='D4976FA739'></tfoot></center><abbr id='D4976FA739'><dir id='D4976FA739'><tfoot id='D4976FA739'></tfoot><noframes id='D4976FA739'>

    • <optgroup id='D4976FA739'><strike id='D4976FA739'><sup id='D4976FA739'></sup></strike><code id='D4976FA739'></code></optgroup>
        1. <b id='D4976FA739'><label id='D4976FA739'><select id='D4976FA739'><dt id='D4976FA739'><span id='D4976FA739'></span></dt></select></label></b><u id='D4976FA739'></u>
          <i id='D4976FA739'><strike id='D4976FA739'><tt id='D4976FA739'><pre id='D4976FA739'></pre></tt></strike></i>

          hotspot

          hotspot

          author:Wikipedia    Page View:9
          Photography of the US department of health and human services in Silver Spring MD
          Manuel Balce Ceneta/AP

          An increasing number of medical device companies are submitting fabricated and unreliable data, the Food and Drug Administration noted Tuesday morning. The data comes from third-party labs hired by device firms to test the quality of their products.

          Triple-check your data or we’ll reject your device, the FDA warned.

          advertisement

          The goal of third-party testing is to ensure a device meets the FDA’s standards in a range of areas, including biocompatibility, sterility, and mechanical performance. The agency wrote that it has noticed an uptick in false data submissions in recent years, particularly from facilities based in China and India. In some cases, the facilities will send data copied from previous device submissions.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more
          Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates
          Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

          DarronCummings/APWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechne

          read more
          Peter Hotez and the public health issue of online harassment
          Peter Hotez and the public health issue of online harassment

          AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

          read more

          Brain MRIs reveal impact of 'toxic stress' on Black children

          ImagesshowingdifferencesingraymattervolumebetweenBlackandwhitechildren(top)andshowingthedifferencesa